Description
MS346 is an inhibitor of bromodomain BRD4. This compound displays anti-inflammatory activity, decreasing the production of NO and pro-inflammatory cytokines in macrophages.
MS346 is an inhibitor of bromodomain BRD4. This compound displays anti-inflammatory activity, decreasing the production of NO and pro-inflammatory cytokines in macrophages.
Cas No. | 1395084-25-9 |
---|---|
Purity | ≥99% |
Formula | C18H17N5O3S |
Formula Wt. | 383.43 |
IUPAC Name | 4-[(E)-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-(2-pyridinyl)benzenesulfonamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zhang G, Plotnikov AN, Rusinova E, et al. Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. J Med Chem. 2013 Nov 27;56(22):9251-64. PMID: 24144283.
Endogenous amino acid sugar involved in cartila...
CDK7 inhibitor
Mycotoxin.
AhR antagonist.
CDK2/4/6 inhibitor
Smac mimetic; IAP inhibitor.
NPC1L1 inhibitor.
FAAH inhibitor.
Alters membrane permeability, prevents transpor...
NSAID; COX-1/2 inhibitor.
c-MET and Ron inhibitor.
mTOR inhibitor.
NSAID; COX-2 inhibitor.
Purine derivative; CDK inhibitor.
D-Seco Paclitaxel is an impurity in the product...
MAO-A/B inhibitor.
Indoloquinazoline alkaloid found in Evodia; COX...
Synthetic ITC, erysolin analog.
Polyketide; CRM1 inhibitor.
AurKB/C inhibitor.